Colgate-Palmolive (CL) Remains Overweight as JPMorgan Sees Headwinds Easing in 2026

Group 1 - Colgate-Palmolive Company (NYSE:CL) is recognized as one of the "Dividend Kings," having increased its dividends for 63 consecutive years, which provides stability in an uncertain economy [3] - The company is focusing on everyday essentials, aiming to protect its market position through increased investment in research and innovation, enhanced marketing for core brands, and quicker responses to changing consumer preferences [3] - JPMorgan has raised its price target for Colgate-Palmolive to $88 from $87, maintaining an Overweight rating, with expectations of improved results as headwinds from 2025 are expected to ease [2] Group 2 - Colgate-Palmolive is managing higher raw material costs by implementing price increases, tighter revenue management, and improving operational efficiency [4] - The company has potential upside from its pet nutrition business, Hill's, which could benefit from the sustained demand for pet products following a surge in pet adoption during the pandemic [4] - The outlook for beverages, household, and personal care sectors remains challenging, but there is optimism for consumption and margins due to lower tariffs and favorable currency movements for multinational companies [2]